Danish pharmaceutical giant Novo Nordisk has launched Awiqli (insulin icodec) in India, introducing the world's first once-weekly basal insulin for adults with Type 1 and Type 2 diabetes. The launch marks a major advancement in diabetes care by reducing the number of insulin injections from 365 per year to just 52, potentially improving treatment adherence among millions of patients.

The U.S. Food and Drug Administration (FDA) has proposed a major overhaul of its drug establishment registration and drug listing regulations, aiming to modernize oversight of pharmaceutical manufacturing and improve visibility across global supply chains. If finalized, the rule would introduce a new regulatory framework for distributed manufacturing and expand registration requirements for certain foreign drug manufacturing establishments that currently fall outside existing regulations.

Applications are invited for the one position of Senior Research Fellow (Project) for the following time-bound sponsored project as per the details given below.

Post : Senior Research Fellow (Project) (One position only)

Name of the project & Duration of the Project : “Investigating the Role of Tfh Cells in Shaping Humoral Immunity in Dengue funded by DBT Tenable till-26.04.2029
Name of the Facility Incharge and Email ID : Dr. Nimesh Gupta Staff Scientist-V nimesh.gupta@nii.ac.in